Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002772.SZ Stock Summary
Top 10 Correlated ETFs
002772.SZ
In the News
002772.SZ Financial details
Company Rating
Sell
Market Cap
3.32B
Income
234.24M
Revenue
1.98B
Book val./share
8.78
Cash/share
5.29
Dividend
0.3
Dividend %
3.82%
Employees
5.6K
Optionable
No
Shortable
Yes
Earnings
21 Apr 2021
P/E
13.1
Forward P/E
-
PEG
-0.07
P/S
1.49
P/B
0.89
P/C
1.45
P/FCF
24.72
Quick Ratio
1.11
Current Ratio
1.83
Debt / Equity
0.83
LT Debt / Equity
0.41
-
-
EPS (TTM)
0.59
EPS next Y
-
EPS next Q
-
EPS this Y
-1353.92%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.23%
Revenue last 5Y
16.29%
Revenue Q/Q
9.51%
EPS Q/Q
3188.24%
-
-
-
-
SMA20
14.29%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
3%
ROE
7%
ROC
0.05%
Gross Margin
26%
Oper. Margin
12%
Profit Margin
12%
Payout
100%
Shs Outstand
393.24M
Shs Float
354.69M
-
-
-
-
Target Price
-
52W Range
5.47-11.93
52W High
-30.36%
52W Low
+53.2%
RSI
52
Rel Volume
1.52
Avg Volume
9.86M
Volume
14.98M
Perf Week
-11.24%
Perf Month
28.09%
Perf Quarter
-
Perf Half Y
-13.05%
-
-
-
-
Beta
0.181
-
-
Volatility
0.36%, 0.8%
Prev Close
0.92%
Price
7.66
Change
-1.67%
002772.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.57 | 3.21 | 4.4 | 4.02 | 5.01 | |
Net income per share | 0.31 | -0.08 | 0.32 | -0.03 | 0.4 | |
Operating cash flow per share | 0.64 | 1 | 1.15 | -1.07 | 1.26 | |
Free cash flow per share | -1.16 | -0.85 | 0.03 | -1.81 | 0.63 | |
Cash per share | 1.31 | 4.56 | 5.64 | 4.8 | 4.32 | |
Book value per share | 7.28 | 7.22 | 8.09 | 8.38 | 8.61 | |
Tangible book value per share | 6.48 | 6.31 | 7.09 | 7.49 | 7.74 | |
Share holders equity per share | 7.28 | 7.22 | 8.09 | 8.38 | 8.61 | |
Interest debt per share | 3.17 | 5.8 | 7.5 | 7.31 | 6.85 | |
Market cap | 2.22B | 2.49B | 3.9B | 3.24B | 3.27B | |
Enterprise value | 2.87B | 3.53B | 5.13B | 4.4B | 4.55B | |
P/E ratio | 19.86 | -85.68 | 36.48 | -262.27 | 20.64 | |
Price to sales ratio | 2.4 | 2.15 | 2.63 | 2.08 | 1.66 | |
POCF ratio | 9.59 | 6.93 | 10.01 | -7.83 | 6.62 | |
PFCF ratio | -5.29 | -8.17 | 407.01 | -4.63 | 13.19 | |
P/B Ratio | 0.84 | 0.96 | 1.43 | 1 | 0.97 | |
PTB ratio | 0.84 | 0.96 | 1.43 | 1 | 0.97 | |
EV to sales | 3.1 | 3.05 | 3.46 | 2.83 | 2.31 | |
Enterprise value over EBITDA | 10.32 | 9.86 | 10.35 | 11.6 | 7.8 | |
EV to operating cash flow | 12.39 | 9.82 | 13.17 | -10.63 | 9.21 | |
EV to free cash flow | -6.84 | -11.58 | 535.65 | -6.28 | 18.34 | |
Earnings yield | 0.05 | -0.01 | 0.03 | 0 | 0.05 | |
Free cash flow yield | -0.19 | -0.12 | 0 | -0.22 | 0.08 | |
Debt to equity | 0.43 | 0.77 | 0.9 | 0.85 | 0.77 | |
Debt to assets | 0.27 | 0.4 | 0.44 | 0.42 | 0.4 | |
Net debt to EBITDA | 2.34 | 2.9 | 2.48 | 3.05 | 2.19 | |
Current ratio | 4.2 | 4.5 | 2.59 | 3.76 | 2.1 | |
Interest coverage | 5.24 | 2.22 | 3.17 | 1.5 | 3.4 | |
Income quality | 2.06 | 5.2 | 2.05 | -7.62 | 3.11 | |
Dividend Yield | 0.02 | 0.03 | 0.03 | 0.05 | 0.05 | |
Payout ratio | 0.44 | -2.69 | 0.97 | -12.04 | 1.08 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.02 | 0.03 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Intangibles to total assets | 0.07 | 0.07 | 0.06 | 0.05 | 0.05 | |
Capex to operating cash flow | -2.81 | -1.85 | -0.98 | 0.69 | -0.5 | |
Capex to revenue | -0.7 | -0.57 | -0.26 | -0.18 | -0.12 | |
Capex to depreciation | -4.55 | -3.48 | -1.69 | -1.11 | -0.89 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0.02 | 0.01 | |
Graham number | 7.13 | 3.62 | 7.59 | 2.45 | 8.83 | |
ROIC | 0.02 | -0.02 | 0.03 | 0 | 0.05 | |
Return on tangible assets | 0.03 | -0.01 | 0.02 | 0 | 0.03 | |
Graham Net | -2.54 | -1.85 | -2.3 | -2.16 | -2.04 | |
Working capital | 1.05B | 1.42B | 1.36B | 2.26B | 1.59B | |
Tangible asset value | 2.34B | 2.27B | 2.39B | 2.9B | 3.04B | |
Net current asset value | -104.86M | -590.64M | -634.35M | -221.63M | -147.62M | |
Invested capital | 0.43 | 0.77 | 0.9 | 0.85 | 0.77 | |
Average receivables | 30.81M | 41.1M | 50.64M | 37.63M | 51.25M | |
Average payables | 142.57M | 161.21M | 147.07M | 144.05M | 180.49M | |
Average inventory | 101.36M | 126.5M | 198.47M | 717.34M | 1.21B | |
Days sales outstanding | 13.62 | 15.04 | 13.21 | 5.07 | 14.99 | |
Days payables outstanding | 87.8 | 67.07 | 45.05 | 44.78 | 51.04 | |
Days of inventory on hand | 63.81 | 56.5 | 88.64 | 337.86 | 311.99 | |
Receivables turnover | 26.79 | 24.27 | 27.64 | 72.03 | 24.36 | |
Payables turnover | 4.16 | 5.44 | 8.1 | 8.15 | 7.15 | |
Inventory turnover | 5.72 | 6.46 | 4.12 | 1.08 | 1.17 | |
ROE | 0.04 | -0.01 | 0.04 | 0 | 0.05 | |
Capex per share | -1.8 | -1.84 | -1.13 | -0.74 | -0.63 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.51 | 1.36 | 1.47 | 1.05 | 1.1 | |
Net income per share | 0.36 | 0.15 | 0.47 | 0 | -0.06 | |
Operating cash flow per share | 0.36 | 0.15 | 0.47 | 0.2 | 0.16 | |
Free cash flow per share | 0.26 | -0.03 | 0.4 | 0.15 | 0.11 | |
Cash per share | 5.26 | 4.38 | 5.5 | 5.52 | 5.29 | |
Book value per share | 8.63 | 8.74 | 8.47 | 9.15 | 8.78 | |
Tangible book value per share | 7.75 | 7.86 | 7.67 | 8.27 | 7.93 | |
Share holders equity per share | 8.63 | 8.74 | 8.47 | 9.15 | 8.78 | |
Interest debt per share | 7.68 | 6.78 | 7.2 | 7.73 | 7.36 | |
Market cap | 2.67B | 3.22B | 3.62B | 4.28B | 3.47B | |
Enterprise value | 4.29B | 4.5B | 4.63B | 5.46B | 4.63B | |
P/E ratio | 4.83 | 13.71 | 4.57 | -1.7K | -39.49 | |
Price to sales ratio | 4.56 | 6.13 | 5.81 | 10.8 | 8 | |
POCF ratio | 19.32 | 54.84 | 18.27 | 55.59 | 54.12 | |
PFCF ratio | 26.84 | -282.82 | 21.42 | 74.18 | 77.23 | |
P/B Ratio | 0.8 | 0.95 | 1.01 | 1.23 | 1.01 | |
PTB ratio | 0.8 | 0.95 | 1.01 | 1.23 | 1.01 | |
EV to sales | 7.32 | 8.56 | 7.44 | 13.79 | 10.69 | |
Enterprise value over EBITDA | 25.82 | 51.69 | 20.87 | 216.89 | -871.92 | |
EV to operating cash flow | 30.98 | 76.58 | 23.39 | 71 | 72.34 | |
EV to free cash flow | 43.04 | -394.97 | 27.41 | 94.74 | 103.23 | |
Earnings yield | 0.05 | 0.02 | 0.05 | 0 | -0.01 | |
Free cash flow yield | 0.04 | 0 | 0.05 | 0.01 | 0.01 | |
Debt to equity | 0.88 | 0.77 | 0.85 | 0.84 | 0.83 | |
Debt to assets | 0.44 | 0.4 | 0.42 | 0.42 | 0.42 | |
Net debt to EBITDA | 9.72 | 14.68 | 4.57 | 47.08 | -219.6 | |
Current ratio | 3.36 | 2.1 | 2.15 | 1.88 | 1.83 | |
Interest coverage | 6.98 | 3.42 | 14.53 | -0.04 | -1.11 | |
Income quality | 1 | 1 | 1 | -122.33 | -2.92 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | |
Payout ratio | 0.19 | 0.8 | 0.09 | -233.64 | -1.06 | |
Sales general and administrative to revenue | 0.06 | -0.04 | 0.03 | -0.01 | 0.07 | |
Research and developement to revenue | 0.01 | 0 | 0 | 0.01 | 0.01 | |
Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
Capex to operating cash flow | -0.28 | -1.19 | -0.15 | -0.25 | -0.3 | |
Capex to revenue | -0.07 | -0.13 | -0.05 | -0.05 | -0.04 | |
Capex to depreciation | 0.28 | -1.01 | -0.44 | -0.29 | 0.14 | |
Stock based compensation to revenue | -0.01 | 0.02 | 0 | 0.01 | -0.01 | |
Graham number | 8.33 | 5.46 | 9.45 | 0.59 | 3.32 | |
ROIC | 0.03 | 0.02 | 0.03 | 0 | 0 | |
Return on tangible assets | 0.02 | 0.01 | 0.03 | 0 | 0 | |
Graham Net | -1.96 | -2.07 | -1.32 | -1.73 | -1.68 | |
Working capital | 2.33B | 1.59B | 1.95B | 1.61B | 1.55B | |
Tangible asset value | 3B | 3.04B | 3.24B | 3.13B | 3.11B | |
Net current asset value | -107.54M | -147.62M | 86.56M | -3.7M | 31.99M | |
Invested capital | 0.88 | 0.77 | 0.85 | 0.84 | 0.83 | |
Average receivables | 17.03M | 57.47M | 78.54M | 76.86M | 53.95M | |
Average payables | 103.9M | 157.24M | 194.68M | 183.68M | 182.33M | |
Average inventory | 1.19B | 1.23B | 1.25B | 1.25B | 1.26B | |
Days sales outstanding | 5.23 | 13.86 | 11.01 | 17.62 | 6.3 | |
Days payables outstanding | 26.35 | 48.33 | 46.82 | 48.17 | 41.65 | |
Days of inventory on hand | 292.43 | 295.4 | 316.13 | 329.78 | 290.03 | |
Receivables turnover | 17.21 | 6.5 | 8.18 | 5.11 | 14.27 | |
Payables turnover | 3.42 | 1.86 | 1.92 | 1.87 | 2.16 | |
Inventory turnover | 0.31 | 0.3 | 0.28 | 0.27 | 0.31 | |
ROE | 0.04 | 0.02 | 0.06 | 0 | -0.01 | |
Capex per share | -0.1 | -0.18 | -0.07 | -0.05 | -0.05 |
002772.SZ Frequently Asked Questions
What is Tianshui Zhongxing Bio-technology Co.,Ltd. stock symbol ?
Tianshui Zhongxing Bio-technology Co.,Ltd. is a CN stock and trading under the symbol 002772.SZ
What is Tianshui Zhongxing Bio-technology Co.,Ltd. stock quote today ?
Tianshui Zhongxing Bio-technology Co.,Ltd. stock price is $7.66 today.
Is Tianshui Zhongxing Bio-technology Co.,Ltd. stock public?
Yes, Tianshui Zhongxing Bio-technology Co.,Ltd. is a publicly traded company.